Dana-Farber/Harvard Cancer Center (DF/HCC) is the largest comprehensive cancer center in the world, bringing together the cancer research efforts of our seven member institutions: Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Children's Hospital Boston, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, and Massachusetts General Hospital.
Funded by a grant from the National Cancer Institute, we have joined these seven renowned Harvard-affiliated medical centers into one collective force dedicated to the fight against cancer. Based in Boston, DF/HCC consists of more than 1,000 researchers with a singular goal -- to find new and innovative ways to combat cancer.
"The CURE program introduces high school and college students from underrepresented populations to the world of cancer research by placing them in real research settings at local cancer research institutions. Our goal is to encourage students to pursue future careers in the biosciences — particularly cancer research — giving practical meaning to academic course work. At the same time, students make a valuable contribution to the DF/HCC research mission. By participating in a program at DF/HCC — an NCI comprehensive cancer center with more than 1000 researchers across seven Harvard institutions — students will learn from experts who are devoted to preventing, treating and curing cancer. Each year, a number of promising students are selected for this unique opportunity to expand and extend their interest in basic, clinical, or population science cancer research or nursing research."